Identification of Influenza Cases During the H1N1 Pandemic in Massachusetts Using Population-Based Hospital Discharge Data.

PLoS Curr

Doctoral Candidate in Clinical and Population Health Research at UMass Medical School and Division of Infectious Diseases and Immunology, University of Massachusetts Medical School. Division of Epidemiology and Immunization, Massachusetts Department of Public Health. ProMED-mail, International Society for Infectious Diseases.

Published: August 2011

Objectives(1) To characterize the epidemiology of H1N1-related hospitalizations in Massachusetts; and (2) to compare characteristics of those hospitalized during periods of seasonal influenza activity and during the H1N1 pandemic. MethodsAuthors applied maximum and minimum criteria to the Massachusetts Hospital Discharge Database to identify H1N1-related hospitalizations. They constructed annual line graphs describing mean frequencies of influenza-like illness(ILI)-related discharges between 2005-2008, and compared these rates to early waves of H1N1 in 2009. ResultsDuring spring and summer 2009, there were significantly higher rates of ILI-related hospital discharges in Massachusetts compared to 2005-2008. Out of 359,344 total discharges between April 26-September 30,2009, H1N1-related hospitalizations ranged from 601 to 10,967 cases. Minimum criteria confirmed that H1N1 affected a younger population (50% were <18 years), with higher rates among African-Americans (18%) and Hispanics (23%) and higher rates of ICU admission (21%) compared to seasonal influenza (39%, 10%, 14%, and 17% respectively). ConclusionsThis is the first population-based assessment of epidemiological characteristics of hospitalized H1N1 cases in Massachusetts, and it is the first to include all possible hospitalized cases in the analysis. The authors confirm that large administrative data sets can detect hospitalizations for influenza during a pandemic, but estimated case counts vary widely depending on selection criteria used. Maximum criteria overestimated H1N1 activity, and those meeting minimum criteria resemble published accounts of H1N1-related hospitalizations closely.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3156440PMC
http://dx.doi.org/10.1371/currents.RRN1256DOI Listing

Publication Analysis

Top Keywords

h1n1-related hospitalizations
12
h1n1 pandemic
8
hospital discharge
8
minimum criteria
8
identification influenza
4
influenza cases
4
h1n1
4
cases h1n1
4
massachusetts
4
pandemic massachusetts
4

Similar Publications

IL-4Rα blockade reduces influenza-associated morbidity in a murine model of allergic asthma.

Respir Res

March 2021

Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Room 166, 1081 Burrard Street, Vancouver, BC, V6Z 1Y6, Canada.

Background: Asthma was identified as the most common comorbidity in hospitalized patients during the 2009 H1N1 influenza pandemic. We determined using a murine model of allergic asthma whether these mice experienced increased morbidity from pandemic H1N1 (pH1N1) viral infection and whether blockade of interleukin-4 receptor α (IL-4Rα), a critical mediator of T2 signalling, improved their outcomes.

Methods: Male BALB/c mice were intranasally sensitized with house dust mite antigen (Der p 1) for 2 weeks; the mice were then inoculated intranasally with a single dose of pandemic H1N1 (pH1N1).

View Article and Find Full Text PDF

[COVID-19: effects on the lungs and heart].

Pathologe

March 2021

Institut für Pathologie, Medizinische Hochschule Hannover (MHH), Carl-Neuberg-Str. 1, 30625, Hannover, Deutschland.

Viral respiratory diseases constitute the most common reasons for hospitalization with more than half of all acute illnesses worldwide. Progressive respiratory failure with pronounced diffuse alveolar damage has been identified as the primary cause of death in COVID-19. COVID-19 pneumonia shares common histopathological hallmarks with influenza (H1N1)-related ARDS, like diffuse alveolar damage (DAD) with edema, hemorrhage, and intra-alveolar fibrin deposition.

View Article and Find Full Text PDF

Are patients with Down syndrome vulnerable to life-threatening COVID-19?

Acta Neurol Belg

June 2021

Medical Educational Institution, MPI Oosterlo, Geel, Belgium.

Patients with Down syndrome are at increased risk of respiratory syncytial virus- and H1N1-related death. Literature on COVID-19 in Down syndrome patients is unavailable thus far. We describe the clinical course of 4 patients with Down syndrome during an outbreak of COVID-19.

View Article and Find Full Text PDF

C-reactive protein as a biomarker of severe H1N1 influenza.

Inflamm Res

January 2019

Public Health Risk Sciences Division, Public Health Agency of Canada, 180 Queen Street West, Toronto, ON, M5V 3L7, Canada.

Background: C-reactive protein (CRP) is an acute-phase reactant downstream of the pro-inflammatory cytokines released during influenza infection. However, the role of this inflammatory marker in influenza severity and complications is yet to be elucidated.

Objectives: We aim to systematically review and evaluate the levels of CRP in severe and non-severe H1N1 influenza cases and assess its utility as a biomarker in predicting the severity of infection.

View Article and Find Full Text PDF

Adult Influenza A (H1N1) Related Encephalitis: A Case Report.

Indian J Crit Care Med

May 2018

Department of Pulmonology and Critical Care, MICU, Fortis Hospital, Mohali, Punjab, India.

The year 2009-2010 saw H1N1 influenza outbreaks occurring in almost all countries of the world, causing the WHO to declare it a pandemic of an alert level of 6. In India, H1N1 influenza outbreaks were again reported in late 2014 and early 2015. Since then, sporadic cases of H1N1 influenza have been reported.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!